Literature DB >> 10565923

Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD.

A Gravet1, M Rondeau, C Harf-Monteil, F Grunenberger, H Monteil, J M Scheftel, G Prévost.   

Abstract

Staphylococcus aureus was isolated as the predominant or only isolate from cultures of stools of 60 patients over 2 years in a university hospital, leading to the collection of 114 isolates. Diarrhea was observed in 90% of the patients. Ninety-eight percent of the patients had received antibiotics in the month before the diarrhea. Ninety-two percent of the S. aureus isolates were methicillin resistant. S. aureus was encountered with antibiotic-associated diarrhea among 47 quite elderly patients affected or not affected by a gastrointestinal disease. Among the antimicrobial treatments, cessation of the previous therapy when possible or rapid application of oral vancomycin therapy was the most appropriate. Analysis of total DNA by pulsed-field gel electrophoresis revealed 27 different SmaI pulsotypes distributed in 15 clusters. The pulsotypes never differed for related isolates from a single patient, even if they originated from patients with bacteremia. S. aureus was not isolated as the predominant isolate in cultures of stools of 57 patients who received an antimicrobial treatment for more than 5 days without diarrhea. Occurence of production of both enterotoxin A and the bicomponent leucotoxin LukE-LukD by the S. aureus isolates was significantly different from that by random isolates. The results strongly suggest that when predominant in stool samples, S. aureus should be considered a possible etiologic agent for some cases of antibiotic-associated diarrhea.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565923      PMCID: PMC85868     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Screening of staphylococci for the toxic shock syndrome toxin-1 (TSST-1) gene.

Authors:  B Jaulhac; M L De Buyser; F Dilasser; G Prevost; Y Piedmont
Journal:  Lett Appl Microbiol       Date:  1991-08       Impact factor: 2.858

2.  Staphylococcic enterocolitis. Report of six cases with two fatalities after intravenous administration of N-(pyrrolidinomethvl) tetracycline.

Authors:  P LUNDSGAARD-HANSEN; A SENN; B ROOS; U WALLER
Journal:  JAMA       Date:  1960-07-02       Impact factor: 56.272

3.  DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates.

Authors:  G Prevost; B Jaulhac; Y Piemont
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 4.  Kits for the detection of some bacterial food poisoning toxins: problems, pitfalls and benefits.

Authors:  M M Brett
Journal:  Symp Ser Soc Appl Microbiol       Date:  1998

5.  Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family.

Authors:  A Gravet; D A Colin; D Keller; R Girardot; H Monteil; G Prévost; R Giradot
Journal:  FEBS Lett       Date:  1998-10-02       Impact factor: 4.124

6.  Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus.

Authors:  T Kodama; T Santo; T Yokoyama; Y Takesue; E Hiyama; Y Imamura; Y Murakami; H Tsumura; K Shinbara; N Tatsumoto; Y Matsuura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

7.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

8.  Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus.

Authors:  J E Coia; L Browning; L Haines; T H Birkbeck; D J Platt
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

9.  Detection of Clostridium difficile toxin with McCoy cell monolayers and cell suspensions and comparison with HeLa cell assay.

Authors:  A C Maniar; H Chubb; T J Louie; T W Williams; W Forsyth; J C Wilt
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

10.  Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene.

Authors:  J L Couch; M T Soltis; M J Betley
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

View more
  33 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

2.  Crystallization and preliminary crystallographic studies of both components of the staphylococcal LukE-LukD leukotoxin.

Authors:  Romain Galy; Fabien Bergeret; Daniel Keller; Lionel Mourey; Gilles Prévost; Laurent Maveyraud
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

3.  A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan.

Authors:  Yoko Takizawa; Ikue Taneike; Saori Nakagawa; Tomohiro Oishi; Yoshiyuki Nitahara; Nobuhiro Iwakura; Kyoko Ozaki; Misao Takano; Teruko Nakayama; Tatsuo Yamamoto
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.

Authors:  N J Asha; D Tompkins; M H Wilcox
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

6.  Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases.

Authors:  A Gravet; P Couppié; O Meunier; E Clyti; B Moreau; R Pradinaud; H Monteil; G Prévost
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus.

Authors:  John M Boyce; Nancy L Havill; Benedicte Maria
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.

Authors:  B G Stiles; A R Garza; R G Ulrich; J W Boles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea.

Authors:  Elizabeth Nicole Sizemore; Kenya Maria Rivas; Jose Valdes; Joshua Caballero
Journal:  BMJ Case Rep       Date:  2012-07-27

Review 10.  Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?

Authors:  D S Acton; M J Tempelmans Plat-Sinnige; W van Wamel; N de Groot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.